IL6 and hepatocellular carcinoma: MO/ascorbic acid–selenium nanoparticles (MO/asc.-Se-NPs) significantly improved antioxidant and anti-inflammatory effects and liver enzyme levels in hepatocellular carcinoma (HCC)-induced Wistar rats, reducing IL-6 and alleviating liver tissue damage [280].